BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 17053382)

  • 1. Pulmonary lymphangitic carcinomatosis (PLC): spectrum of FDG-PET findings.
    Acikgoz G; Kim SM; Houseni M; Cermik TF; Intenzo CM; Alavi A
    Clin Nucl Med; 2006 Nov; 31(11):673-8. PubMed ID: 17053382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary Lymphangitic Carcinomatosis: Diagnostic Performance of High-Resolution CT and
    Jreige M; Dunet V; Letovanec I; Prior JO; Meuli RA; Beigelman-Aubry C; Schaefer N
    J Nucl Med; 2020 Jan; 61(1):26-32. PubMed ID: 31227574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FDG PET/CT in assessment of pulmonary lymphangitic carcinomatosis.
    Prakash P; Kalra MK; Sharma A; Shepard JA; Digumarthy SR
    AJR Am J Roentgenol; 2010 Jan; 194(1):231-6. PubMed ID: 20028927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of 18F-fluorodeoxyglucose positron emission tomography in detecting extrahepatic metastasis in pretreatment staging of hepatocellular carcinoma.
    Yoon KT; Kim JK; Kim DY; Ahn SH; Lee JD; Yun M; Rha SY; Chon CY; Han KH
    Oncology; 2007; 72 Suppl 1():104-10. PubMed ID: 18087190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary lymphangitic carcinomatosis without concurrent liver metastasis from colon cancer detected using 18F-FDG PET/CT: A case report.
    Wang Y; Su M; Li L
    Medicine (Baltimore); 2019 Oct; 98(41):e17446. PubMed ID: 31593099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pulmonary lymphangitic carcinomatosis].
    Gao Z; Deng X; Cao Z
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Dec; 21(12):739-41. PubMed ID: 11480078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymph node staging of gastric cancer using (18)F-FDG PET: a comparison study with CT.
    Yun M; Lim JS; Noh SH; Hyung WJ; Cheong JH; Bong JK; Cho A; Lee JD
    J Nucl Med; 2005 Oct; 46(10):1582-8. PubMed ID: 16204706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical features and diagnosis of pulmonary lymphangitic carcinomatosis].
    Zhang K; Huang Y
    Ai Zheng; 2006 Sep; 25(9):1127-30. PubMed ID: 16965655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The application of 18F-fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer].
    Xu HF; Liu Y; Zhang JH; Zhou RS; Zhou FH; Yuan MH
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb; 28(2):108-11. PubMed ID: 15854393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of integrated FDG PET/CT imaging in pulmonary carcinoid tumours.
    Krüger S; Buck AK; Blumstein NM; Pauls S; Schelzig H; Kropf C; Schumann C; Mottaghy FM; Hombach V; Reske SN
    J Intern Med; 2006 Dec; 260(6):545-50. PubMed ID: 17116005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorodeoxyglucose positron emission tomography pattern of pulmonary lymphangitic carcinomatosis.
    Digumarthy SR; Fischman AJ; Kwek BH; Aquino SL
    J Comput Assist Tomogr; 2005; 29(3):346-9. PubMed ID: 15891505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of small pulmonary nodules with little or no 18F-FDG uptake on PET/CT images of patients with nonthoracic malignancies.
    O JH; Yoo IeR; Kim SH; Sohn HS; Chung SK
    J Nucl Med; 2007 Jan; 48(1):15-21. PubMed ID: 17204694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative diagnosis of lymph node metastases of colorectal cancer by FDG-PET/CT.
    Tsunoda Y; Ito M; Fujii H; Kuwano H; Saito N
    Jpn J Clin Oncol; 2008 May; 38(5):347-53. PubMed ID: 18424814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of FDG-PET in the assessment of survival prognosis in melanoma.
    Pleiss C; Risse JH; Biersack HJ; Bender H
    Cancer Biother Radiopharm; 2007 Dec; 22(6):740-7. PubMed ID: 18158764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastasis of the gastrointestinal tract: FDG-PET imaging.
    Hayasaka K; Nihashi T; Matsuura T; Yagi T; Nakashima K; Kawabata Y; Ito K; Katoh T; Sakata K; Harada A
    Ann Nucl Med; 2007 Aug; 21(6):361-5. PubMed ID: 17705017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In search of an unknown primary tumour presenting with cervical metastases: performance of hybrid FDG-PET-CT.
    Wartski M; Le Stanc E; Gontier E; Vilain D; Banal A; Tainturier C; Pecking AP; Alberini JL
    Nucl Med Commun; 2007 May; 28(5):365-71. PubMed ID: 17414886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Diagnostic Value of FDG PET/CT and Thin-Slice High-Resolution Chest CT in Pulmonary Intravascular Metastasis.
    Ji Y; Shao CC; Cui Y; Cui K; Shao GR; Zheng JS
    AJR Am J Roentgenol; 2021 Mar; 216(3):769-775. PubMed ID: 33405948
    [No Abstract]   [Full Text] [Related]  

  • 18. Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan.
    Chung JK; So Y; Lee JS; Choi CW; Lim SM; Lee DS; Hong SW; Youn YK; Lee MC; Cho BY
    J Nucl Med; 1999 Jun; 40(6):986-92. PubMed ID: 10452315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of intrathoracic lesions detected by 18F-fluorodeoxyglucose positron emission tomography in the management of patients with head and neck cancer.
    Roh JL; Ryu CH; Kim JS; Lee JS; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2007 Sep; 43(8):757-63. PubMed ID: 17112773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of unknown primary tumours and distant metastases in patients with cervical metastases: value of FDG-PET versus conventional modalities.
    Regelink G; Brouwer J; de Bree R; Pruim J; van der Laan BF; Vaalburg W; Hoekstra OS; Comans EF; Vissink A; Leemans CR; Roodenburg JL
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29(8):1024-30. PubMed ID: 12173016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.